| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Platelets in inflammation and atherogenesis.
|
J Clin Invest
|
2005
|
4.10
|
|
2
|
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.
|
Eur Heart J
|
2006
|
3.21
|
|
3
|
Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity.
|
JACC Cardiovasc Imaging
|
2009
|
1.49
|
|
4
|
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
|
Circulation
|
2006
|
1.40
|
|
5
|
Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells.
|
Circulation
|
2007
|
1.39
|
|
6
|
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
|
Circ Res
|
2007
|
1.27
|
|
7
|
Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.
|
FASEB J
|
2006
|
1.14
|
|
8
|
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.07
|
|
9
|
Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.
|
Arterioscler Thromb Vasc Biol
|
2011
|
1.02
|
|
10
|
EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation.
|
Atherosclerosis
|
2009
|
0.99
|
|
11
|
Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment.
|
Blood
|
2004
|
0.98
|
|
12
|
Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
|
Diabetes Care
|
2007
|
0.97
|
|
13
|
Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention.
|
J Am Soc Nephrol
|
2011
|
0.96
|
|
14
|
The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
|
Circ Res
|
2012
|
0.90
|
|
15
|
Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis.
|
Curr Med Chem
|
2008
|
0.89
|
|
16
|
EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy.
|
Int J Cardiol
|
2011
|
0.89
|
|
17
|
Percutaneous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry.
|
Catheter Cardiovasc Interv
|
2014
|
0.88
|
|
18
|
Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome.
|
Eur Heart J
|
2006
|
0.88
|
|
19
|
Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
|
Eur Heart J
|
2009
|
0.88
|
|
20
|
Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.
|
Clin Res Cardiol
|
2010
|
0.88
|
|
21
|
Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro.
|
J Mol Cell Cardiol
|
2009
|
0.88
|
|
22
|
Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease.
|
Atherosclerosis
|
2010
|
0.88
|
|
23
|
Platelet-induced differentiation of endothelial progenitor cells.
|
Semin Thromb Hemost
|
2007
|
0.88
|
|
24
|
Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease.
|
Clin Res Cardiol
|
2008
|
0.88
|
|
25
|
Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties.
|
Mol Pharmacol
|
2004
|
0.87
|
|
26
|
The serum- and glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes.
|
Blood
|
2011
|
0.86
|
|
27
|
Platelet-associated LIGHT (TNFSF14) mediates adhesion of platelets to human vascular endothelium.
|
Thromb Haemost
|
2007
|
0.86
|
|
28
|
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
|
Thromb Haemost
|
2006
|
0.86
|
|
29
|
EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction.
|
Thromb Haemost
|
2009
|
0.86
|
|
30
|
Human herpesvirus 6 subtype A-associated myocarditis with 'apical ballooning'.
|
Can J Cardiol
|
2007
|
0.85
|
|
31
|
Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases.
|
Cardiovasc Res
|
2014
|
0.85
|
|
32
|
Left ventricular site-directed biopsy guided by left ventricular voltage mapping: a proof of principle.
|
Int J Cardiol
|
2013
|
0.85
|
|
33
|
Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis.
|
J Mol Cell Cardiol
|
2012
|
0.84
|
|
34
|
Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions.
|
J Mol Med (Berl)
|
2010
|
0.84
|
|
35
|
Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
|
Eur Heart J
|
2008
|
0.83
|
|
36
|
Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.
|
Eur J Heart Fail
|
2012
|
0.83
|
|
37
|
Cardiac magnetic resonance imaging in patients undergoing percutaneous mitral valve repair with the MitraClip system.
|
Clin Res Cardiol
|
2014
|
0.83
|
|
38
|
Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function.
|
EuroIntervention
|
2016
|
0.83
|
|
39
|
The Extracellular Matrix Metalloproteinase Inducer (EMMPRIN, CD147) - a potential novel target in atherothrombosis prevention?
|
Thromb Res
|
2013
|
0.82
|
|
40
|
ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
|
Thromb Haemost
|
2005
|
0.82
|
|
41
|
Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).
|
Basic Res Cardiol
|
2009
|
0.81
|
|
42
|
Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
|
Circ Cardiovasc Interv
|
2009
|
0.81
|
|
43
|
Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation.
|
Blood
|
2012
|
0.81
|
|
44
|
Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome.
|
Thromb Haemost
|
2009
|
0.81
|
|
45
|
Lyme carditis--diagnosis, treatment and prognosis.
|
Dtsch Arztebl Int
|
2015
|
0.81
|
|
46
|
CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis.
|
Semin Thromb Hemost
|
2010
|
0.80
|
|
47
|
Reverse left ventricular remodeling after percutaneous mitral valve repair: strain analysis by speckle tracking echocardiography and cardiac magnetic resonance imaging.
|
Int J Cardiol
|
2013
|
0.79
|
|
48
|
Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery.
|
Clin Res Cardiol
|
2009
|
0.78
|
|
49
|
Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous.
|
Int J Cardiol
|
2010
|
0.78
|
|
50
|
Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
|
Am Heart J
|
2008
|
0.78
|
|
51
|
Electrophysiological characterization of scars detected by contrast enhanced magnetic resonance imaging in patients with non-ischemic cardiomyopathy.
|
Int J Cardiol
|
2012
|
0.77
|
|
52
|
Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.77
|
|
53
|
New aspects of integrin-mediated leukocyte adhesion in inflammation: regulation by haemostatic factors and bacterial products.
|
Curr Mol Med
|
2003
|
0.77
|
|
54
|
Fusion of MR coronary angiography and viability imaging: feasibility and clinical value for the assignment of myocardial infarctions.
|
Eur J Radiol
|
2011
|
0.77
|
|
55
|
Chest pain and reversible midventricular ballooning in a woman after witnessing sudden cardiac death: a possible variant of takotsubo cardiomyopathy.
|
Can J Cardiol
|
2009
|
0.76
|
|
56
|
Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease.
|
Clin Res Cardiol
|
2010
|
0.76
|
|
57
|
Successful thrombolysis of mechanical mitral valve prosthesis in a patient with cardiogenic shock.
|
BMJ Case Rep
|
2009
|
0.75
|
|
58
|
Therapeutic potential and strategies against leukocyte-platelet interaction in atherosclerosis.
|
Curr Vasc Pharmacol
|
2012
|
0.75
|
|
59
|
Management of perioperative stent thrombosis in patients undergoing surgery.
|
Platelets
|
2010
|
0.75
|
|
60
|
Increased platelet Ca2+ channel Orai1 expression upon platelet activation and in patients with acute myocardial infarction.
|
Thromb Haemost
|
2013
|
0.75
|
|
61
|
Antithrombotic triple therapy in a patient with multiple thrombi, subacute myocardial infarction and coronary stent implantation.
|
Clin Res Cardiol
|
2008
|
0.75
|
|
62
|
Loss of protease activity of ADAM15 abolishes protective effects on plaque progression in atherosclerosis.
|
Int J Cardiol
|
2011
|
0.75
|
|
63
|
Challenges in the treatment of patients with essential thrombocythemia and acute coronary syndrome.
|
J Thromb Thrombolysis
|
2007
|
0.75
|
|
64
|
[After coronary stent implantation: optimal individualized antiplatelet therapy].
|
Pharm Unserer Zeit
|
2009
|
0.75
|
|
65
|
S100A9 induces monocyte/ macrophage migration via EMMPRIN.
|
Thromb Haemost
|
2016
|
0.75
|